Загрузка...
Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial
BACKGROUND: Due to increasing drug resistance, artemisinin-based combination chemotherapy (ACT) has become the first-line treatment of falciparum malaria in many endemic countries. However, irreversible ototoxicity associated with artemether/lumefantrine (AL) has been reported recently and suggested...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2559845/ https://ncbi.nlm.nih.gov/pubmed/18796142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-7-179 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|